About: Debbie L Shawcross

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Debbie L Shawcross Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

British physician and academic

Attributes	Values
rdf:type	Item
description	연구원 (ko) araştırmacı (tr) wetenschapper (nl) дослідниця (uk) изилдөөчү (ky) հետազոտող (hy) British physician and academic (en)
rdfs:label	Debbie L Shawcross (en) Debbie L Shawcross (es) Debbie L Shawcross (nl) Debbie L Shawcross (ast)
skos:prefLabel	Debbie L Shawcross (en) Debbie L Shawcross (es) Debbie L Shawcross (nl) Debbie L Shawcross (ast)
name	Debbie L Shawcross (en) Debbie L Shawcross (es) Debbie L Shawcross (nl) Debbie L Shawcross (ast)
LinkedIn personal profile ID	wds:Q64386408-e578fb99-4ef8-4a28-b8ba-4859e01585d5
LinkedIn personal profile ID	debbie-shawcross-a75ba812
given name	wds:Q64386408-057A8B86-86EA-41A0-8A82-221BD546BED7
given name	Debbie
instance of	wds:Q64386408-6D62E347-D50E-4E75-8E4F-BCAE6F6AE3FB
instance of	Homo sapiens
Google Knowledge Graph ID	wds:Q64386408-1EE599D0-23EE-418D-A5B9-4740C21577BB
Google Knowledge Graph ID	http://g.co/kg/g/11fynczx0h
Google Knowledge Graph ID	/g/11fynczx0h
ResearchGate profile ID	wds:Q64386408-9c3caeb2-4b00-861c-ce4a-afdcac6fc4b5
ResearchGate profile ID	Debbie-Shawcross
skos:altLabel	Debbie L. Shawcross (fr) Debbie Lindsay Shawcross (en) Debbie Shawcross (en)
occupation	wds:Q64386408-AB0661AD-3515-47DE-86E6-D311FE5B661F
employer	wds:Q64386408-E404ECE2-0D18-4C83-88A7-FA2F3B7A739B
sex or gender	wds:Q64386408-9cc9d4dc-491b-3a38-9c3f-6657e3f38bb1
occupation	researcher
employer	King's College London
sex or gender	female organism
ORCID iD	wds:Q64386408-3CA2962B-DA58-466C-B3B0-61834A96ECA4
Dimensions author ID	wds:Q64386408-E9DF18D5-A68A-4B9F-A3F1-C4995A8AFF1A
ORCID iD	https://orcid.org/0000-0001-6133-4619
ORCID iD	0000-0001-6133-4619
Dimensions author ID	01022012054.03
ResearcherID	wds:Q64386408-01173B1C-0F5F-448F-A5DD-B349FDD74EB1
Publons author ID	wds:Q64386408-BA6A73D0-8759-411E-B5F5-5A7AEA119FE6
ResearcherID	H-9669-2012
Publons author ID	1189176
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64386408 Debbie Shawcross
is author of	CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocyte The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation Role of ammonia and inflammation in minimal hepatic encephalopathy. Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis Ammonia impairs neutrophil phagocytic function in liver disease Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis. Inflammation and hepatic encephalopathy. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis Systemic inflammation and ammonia in hepatic encephalopathy. Recent insights into the pathogenesis of hepatic encephalopathy and treatments Changing face of hepatic encephalopathy: role of inflammation and oxidative stress. Neutrophil gelatinase--associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation. The impact of organ dysfunction in cirrhosis: survival at a cost? Dispelling myths in the treatment of hepatic encephalopathy. The molecular pathogenesis of hepatic encephalopathy. The severity of circulating neutrophil dysfunction in patients with cirrhosis is associated with 90-day and 1-year mortality. Circulating neutrophil dysfunction in acute liver failure. Cerebral oedema is rare in acute-on-chronic liver failure patients presenting with high-grade hepatic encephalopathy High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial The 6-month abstinence rule in liver transplantation. Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation. Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure*. Endotoxemia produces coma and brain swelling in bile duct ligated rats Pathophysiology of cerebral oedema in acute liver failure The neurological manifestations of acute liver failure Ammonia and hepatic encephalopathy: the more things change, the more they remain the same. Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. Should a biopsy precede liver resection or transplantation for presumed hepatocellular carcinoma when the alfa fetoprotein is normal? Treatment of hepatic encephalopathy: it's not lactulose Clinical science workshop: targeting the gut-liver-brain axis Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy? Increased Survival for Patients With Cirrhosis and Organ Failure in Liver Intensive Care and Validation of the Chronic Liver Failure-Sequential Organ Failure Scoring System Polymorphisms in ABCB11 and ATP8B1 Associated with Development of Severe Intrahepatic Cholestasis in Hodgkin's Lymphoma Rifaximin is an efficacious treatment for the Parkinsonian phenotype of hepatic encephalopathy. Defective monocyte oxidative burst predicts infection in alcoholic hepatitis and is associated with reduced expression of NADPH oxidase α1-Antitrypsin deficiency. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis. Comparison of scoring systems and outcome of patients admitted to a liver intensive care unit of a tertiary referral centre with severe variceal bleeding Acute alcoholic hepatitis and cellular Th1 immune responses to alcohol dehydrogenase Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease Targeting the gut-liver-immune axis to treat cirrhosis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software